{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["56(9)"],"submitter":["Russo D"],"pubmed_abstract":["The Transplant Centers belonging to Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO) conducted a survey with the aim of evaluating the effect of SARS-CoV2 pandemic on the allogeneic transplant activity in Italy. The pandemic period from 1/3/2020 to 31/7/2020 was compared with the same period in 2019. Overall, in 2020 there was a 2.4% reduction in the number of allo-HCT cases compared to 2019. Interestingly, this deflection did not affect the acute leukemia cases (+5.7% in 2020). The use of peripheral blood-derived stem cells (+10.7%) and cryopreservation (97.4% of the centers) was highly adopted in 2020. Despite the sanitary emergency, almost all of the surveyed centers declared no impact of SARS-CoV2 pandemic on the transplant timing and outcomes, and the sanitary policy was posi"],"journal":["Bone marrow transplantation"],"pagination":["2272-2275"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8054130"],"repository":["biostudies-literature"],"pubmed_title":["Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)."],"pmcid":["PMC8054130"],"pubmed_authors":["Russo D","Faraci M","Narni F","Zallio F","Vacca A","Proia A","Leoni A","GITMO Centers","Ciceri F","Prete A","Oldani E","Carella AM","Dellacasa CM","Onida F","Sica S","Farina M","Piemontese S","Caravelli D","Federico V","Pelosini M","Ronconi S","Cavattoni IM","Iori AP","Mirabile M","Martino M","Maffeis M","Storti G","Nozzoli C","Mordini N","Picardi A","Elice F","Carluccio P","Guiducci B","Marcatti M","Ferrario A","Secondino S","Fagioli F","Bonifazi F","Calore E","Skert C","De Simone G","Michieli M","Bernardi S","Malagola M","Falcioni S","Tringali S","Polverelli N","Zecca M","Olivieri A","Sacchi N","Balduzzi A","Zuffa E","Rabusin M","Pastore D","Facchini L","De Gobbi M","Imola M","Mammoliti S","Grassi A","Armiento D"],"additional_accession":[]},"is_claimable":false,"name":"Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey).","description":"The Transplant Centers belonging to Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO) conducted a survey with the aim of evaluating the effect of SARS-CoV2 pandemic on the allogeneic transplant activity in Italy. The pandemic period from 1/3/2020 to 31/7/2020 was compared with the same period in 2019. Overall, in 2020 there was a 2.4% reduction in the number of allo-HCT cases compared to 2019. Interestingly, this deflection did not affect the acute leukemia cases (+5.7% in 2020). The use of peripheral blood-derived stem cells (+10.7%) and cryopreservation (97.4% of the centers) was highly adopted in 2020. Despite the sanitary emergency, almost all of the surveyed centers declared no impact of SARS-CoV2 pandemic on the transplant timing and outcomes, and the sanitary policy was posi","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Sep","modification":"2025-04-18T21:39:27.376Z","creation":"2022-02-09T15:50:45.694Z"},"accession":"S-EPMC8054130","cross_references":{"pubmed":["33875810"],"doi":["10.1038/s41409-021-01287-w"]}}